Suzuki Ryo
Faculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University.
Biol Pharm Bull. 2017;40(11):1828-1832. doi: 10.1248/bpb.b17-00465.
It is now well known that immunoglobulin E (IgE) and mast cells (MCs) are important participants in allergic diseases. MCs contain electron-dense secretory granules which are filled with inflammatory mediators. The interaction of an allergen (antigen) with an antigen-specific IgE-bound high-affinity receptor for IgE (FcεRI) is an essential step in MC activation as well as subsequent downstream signaling events. What we know is that IgE and FcεRI activate a complex regulatory network (i.e., signaling molecules and messengers) that governs both the type of MC activation and the symptoms of allergic disease. This review focuses on recent discoveries that shed new light on FcεRI signaling networks, holding promise for the development of new therapeutic solutions in the treatment of allergic diseases.
现在众所周知,免疫球蛋白E(IgE)和肥大细胞(MCs)是过敏性疾病的重要参与者。肥大细胞含有充满炎症介质的电子致密分泌颗粒。变应原(抗原)与抗原特异性IgE结合的IgE高亲和力受体(FcεRI)的相互作用是肥大细胞激活以及随后下游信号事件的关键步骤。我们所知道的是,IgE和FcεRI激活一个复杂的调节网络(即信号分子和信使),该网络控制肥大细胞激活的类型和过敏性疾病的症状。本综述重点关注最近的发现,这些发现为FcεRI信号网络提供了新的见解,有望为过敏性疾病的治疗开发新的治疗方案。